OSIRIX DICOM VIEWER RISK SOFTWARE

The primary strategy to reduce mortality is early detection and treatment based on medical imaging technologies. Our evaluation shows that advanced visualization and suitable interfaces can also be found in the open source field and not only in commercial products.īreast cancer is one of the most commonly occurring types of cancer among women. Weasis is superior for workflow optimization in clinical trials. Focusing on open source components, MIPAV is the best candidate for 3D imaging as well as DICOM communication. Interfaces needed for decentral viewing in web-based systems are offered by Oviyam, Weasis, and Xero.

The viewers ImageJ, MicroView, MIPAV, and OsiriX Lite offer all included 3D-rendering features for advanced viewing. Suitable DICOM interfaces for central viewing in hospitals are provided by GingkoCADx, MIPAV, and OsiriX Lite. On the average, 4.48 and 1.43 of overall 8 2D and 5 3D image viewing criteria are satisfied, respectively. They include (i) platform, (ii) interface, (iii) support, (iv) two-dimensional (2D), and (v) three-dimensional (3D) viewing. The evaluation criteria are obtained from application scenarios in clinical research rather than patient care. In this paper, a comprehensive evaluation of 28 DICOM viewers is performed.

OSIRIX DICOM VIEWER RISK SOFTWARE

Imaging biomarkers and image-based surrogate endpoints in clinical trials and medical registries require DICOM viewer software with advanced functionality for visualization and interfaces for integration. The digital imaging and communications in medicine (DICOM) protocol is the leading standard for image data management in healthcare.

Osirix dicom viewer risk